Intraday Data provided by FACTSET and subject to terms of use. document.getElementsByTagName("head")[0].appendChild(script); With a 5-year investment, the revenue is expected to be around +256.76%. 'id' : '101' , The firm owned 1,287,558 shares of the companyâs stock after buying an additional 27,853 shares during the quarter. Medical professionals in charge of the trial said that these results could be “game-changing” for the millions of patients with the mental disorder, a recommendation which sent the stock flying. "443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!e.protocol||":"===e.protocol||e.protocol===n.protocol,a=e.hostname===document.domain&&e.port===n.port;return r.sameOrigin=i&&(!e.hostname||a),r}},{}],17:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(s(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(21),s=t(22),c=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(c.emit((o? Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. This browser is no longer supported at MarketWatch. Shares of Karuna Therapeutics (NASDAQ:KRTX) shot up 10.7% during trading on Tuesday . KRTX: Get the latest Karuna Therapeutics stock price and detailed information including KRTX news, historical charts and realtime prices. 'cat' : 'quotes' , BlackRock Inc. owned 4.84% of Karuna [â¦] return true; }; BlackRock Inc. boosted its stake in shares of Karuna Therapeutics (NASDAQ:KRTX) by 2.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. KRTX: Get the latest Karuna Therapeutics stock price and detailed information including KRTX news, historical charts and realtime prices. var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; 'site' : 'cnbc.com-relaunch' , 'sys_name' : 'blog' , BOSTON, Mass. KRTX 104.65 0.42 (0.40%). US Bancorp DE boosted its holdings in Karuna Therapeutics by 23.7% in the second quarter. if (typeof mps.getAd != "function") mps.getAd = function(adunit) { View insider buying and selling activity for Karuna Therapeutics or or view top insider-buying stocks. head.insertBefore(mpsload, head.firstChild) Subscriber Agreement & Terms of Use,
Wall Street Stock Market & Finance report, prediction for the future: You'll find the Karuna Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Karuna Therapeutics's KRTX shares and potentially its market environment have been in a bullish … The firm set a “buy” rating and a $150.00 price target on the stock. }; UBS Group AG boosted its stake in Karuna Therapeutics by 17.8% in the second quarter. } Karuna Therapeutics stock price target raised to $126 from $117 at Wedbush Jun. Karuna Therapeutics (NASDAQ:KRTX) COO Andrew Craig Miller sold 5,000 shares of the companyâs stock in a transaction that occurred on Thursday, December 10th. Altering the story of serious mental illness. 11 Wall Street analysts have issued ratings and price targets for Karuna Therapeutics in the last 12 months. for (var i in mps.response.dart.adunits) { Valuing Karuna Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Karuna Therapeutics's overall performance. return false; Date.now() : (function() { return +new Date })(); The company traded as high as $94.39 and last traded at … Shares of Karuna Therapeutics (NASDAQ:KRTX) had skyrocketed 233.1% higher as of 11:03 a.m. EST on Monday. 2, 2020 at 7:05 a.m. var _regex = /([^=&/<>()[].,;:s@"]+(.[^=&/<>()[].,;:s@"]+)*)@(([[0-9]{1,3}.[0-9]{1,3}.[0-9]{1,3}.[0-9]{1,3}])|(([a-zA-Z-0-9]+. Karuna Therapeutics. Karuna Therapeutics, Inc. Common Stock (KRTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Maxim Group’s price objective suggests a potential upside of 54.64% from the stock’s current price. Mergers Bounced Back in 2020. See Karuna Therapeutics, Inc. real time stock price, historical quotes and price charts. mpsload.src = "//" + mpsopts.host + "/fetch/ext/load-" + mpscall.site + ".js?nowrite=2"; (t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(22),a="nr@original",s=Object.prototype.hasOwnProperty,c=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,s,c;try{a=this,r=i(arguments),s="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],s])}u(e+"start",[r,a,o],s);try{return c=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],s),d}finally{u(e+"end",[r,a,c],s)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,s,c,f="-"===o.charAt(0);for(c=0;c
Karuna Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need. Privacy Notice, and
Find real-time KRTX - Karuna Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. if (!mps._ext || !mps._ext.loaded) { Company insiders that have bought Karuna Therapeutics stock in the last two years include Arch Venture Partners Ix, Llc, Heather Preston, James Healy, and Steven M Paul. 'title' : 'Detailed Quote' , Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced that senior management will ⦠Intraday data delayed at least 15 minutes or per exchange requirements. Like all ChartIQ markers, the object itself is managed by the chart, so when you scroll the chart the object moves with you. "updatecorrelator" : true (function(){ Karuna Therapeutics Q3 EPS $(0.71) Down From $(0.39) YoY Benzinga Newsdesk Thu, 05 Nov 2020 06:15:07 -0500 Overview Of Value Stocks In The Healthcare Sector … 'is_content' : '0' , Get instant access to a free live streaming chart of the Karuna Therapeutics Inc Stock. }, mpsopts = { As of late, it has definitely been a great time to be an investor Karuna Therapeutics, Inc. (NASDAQ:KRTX) . mps._log('**** LOADED: cnbc-cms-header-insert'); The shares were sold at an average price of $94.82, for a total value of $474,100.00. This is an example of a complex marker which can contain html, video, images, css, and animations. The firm owned 1,287,558 shares of the company’s stock after buying an additional 27,853 shares during the quarter. document.getElementsByTagName('meta')['tp:PreferredRuntimes'].setAttribute("content", "flash,html5"); Sign up for free newsletters and get more CNBC delivered to your inbox, Get this delivered to your inbox, and more info about our products and services.Â, © 2020 CNBC LLC. // } (function() { mps._queue.mpsinit = mps._queue.mpsinit || []; POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Troy Ignelzi, Jason Brown and Mia Kelley, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Karuna Therapeutics, Inc. (the "Company"), (i) ⦠!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),f.on("xhr-load-removed",function(t,e){var n=""+p(t)+! {key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t("ee").get("jsonp"),f=t(24)(c);if(e.exports=c,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(. if (typeof(window._mpspixZ) != 'string') { Valuing Karuna Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Karuna Therapeutics's overall performance. var script = document.createElement("script"); 'template' : 'quote_custom_redesign' , By using this site you agree to the
We have some new features we think you'll like. script.setAttribute("src", "//www.npttech.com/advertising.js"); Karuna Therapeutics Q3 EPS $(0.71) Down From $(0.39) YoY Benzinga Newsdesk Thu, 05 Nov 2020 06:15:07 -0500 Overview Of Value Stocks In ⦠mps._urlContainsEmail = function() { Karuna Therapeutics, Inc. Common Stock (KRTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View Karuna Therapeutics, Inc. KRTX investment & stock information. 'adunits' : 'Flex Ad First|Quote Desktop Badge 1|Quote Desktop Badge 2|Quote Desktop Badge 3|Quote Desktop Badge 4|Quote Desktop Badge 5|Quote Desktop News Strip|Top Banner' , 'cag[company]' : 'Karuna Therapeutics Inc' , mps.__timer = Date.now ? 'https' : 'http') + '://pix.nbcuni.com/a-pii.gif?X=piiblock&S=' + mps.pagevars.instance + '&P=' + mps.pagevars.mpsid + '&A=' + i + '&U=' + encodeURIComponent(window.location.href) + '&_=' + window._mpspixZ; Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. Cookie Notice. Karuna Therapeutics. }); if(typeof document.getElementsByTagName('meta')['tp:PreferredRuntimes'] === 'object') { mps._queue.adview = mps._queue.adview || []; US Bancorp DE boosted its holdings in Karuna Therapeutics by 23.7% in the second quarter. mps.__intcode = "v2"; 'subtype' : 'blog' , BlackRock Inc. boosted its stake in shares of Karuna Therapeutics (NASDAQ:KRTX) by 2.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. 'hline' : 'quotes' , return '' KRTX, Karuna Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Following the completion of the sale, the chief operating officer now owns 45,500 shares in the […] var dynamic_yield_enabled = 1 'cag[brand]' : 'none' , document.addEventListener("DOMContentLoaded", function(event) { The high price target for KRTX is $150.00 and the low price target for … if (mps.response && mps.response.dart && typeof(mps.response.dart.adunits) === 'object') { })(); var _qs = window.location.href; 'type' : 'quote' , mps._queue = mps._queue || {}; All Rights Reserved. Karuna Therapeutics (NASDAQ:KRTX) Price Target and Consensus Rating 11 Wall Street analysts have issued ratings and price targets for Karuna Therapeutics in the last 12 months. February gold settles $2.80, or 0.1%, lower at $1,880.40/oz. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Coherus BioSciences reported earnings per share at 0.81, whereas in Q1 earnings per share ⦠'); mps._queue.mpsinit.push(function() { Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Their average twelve-month price target is $130.20, predicting that the stock has a possible upside of 24.41%. Bill Ackman’s Fund Is Still a Cheap Way to Play a Ride Up, Take a look inside Candice Bergen’s $18 million East Hampton country house, Karuna Therapeutics stock price target raised to $126 from $117 at Wedbush, Karuna Therapeutics started at outperform with $125 stock price target at Oppenheimer, Karuna Therapeutics started at buy with $126 stock price target at Stifel Nicolaus, Karuna Therapeutics stock price target raised to $134 from $38 at Wedbush, Karuna Therapeutics started at outperform with $38 stock price target at Wedbush, Karuna Therapeutics' stock more than triples after upbeat trial results of schizophrenia treatment, Karuna Therapeutics sets IPO terms, to be valued at up to $363 million, Karuna Therapeutics (KRTX) Receives a Buy from Oppenheimer, Kodiak Sciences Has Been a Bonanza for Early Shareholders, Top Analyst Upgrades and Downgrades: Ally, Apple, Autodesk, Boston Beer, Disney, DocuSign, HP, Masco, Qualcomm, Tyson, Vornado, More, Why You Shouldn't Bet Against Karuna Therapeutics (KRTX) Stock, Surging Earnings Estimates Signal Good News for Karuna Therapeutics (KRTX), The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education, 5 Top Mid-Cap Stocks Surging Despite Coronavirus Concerns. Get Karuna Therapeutics Inc (KRTX:NASDAQ) real-time stock quotes, news and financial information from CNBC. }. Create a list of the investments you want to track. mps._queue.refreshads = mps._queue.refreshads || []; mps._debug('[MPS]: email address detected in url, bypass gpt. } // By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. if (typeof adunit != "string") return false; script.setAttribute("onload", "setAdblockerCookie(false);"); SPACs Could Support Deal Activity Next Year. There are currently no items in this Watchlist. On December 22, 2020, the board of directors (the "Board") of Karuna Therapeutics, Inc. (the "Company") appointed Denice Torres as a member of the Company's Board, effective immediately.
UBS Group AG boosted its stake in Karuna Therapeutics by 17.8% in the second quarter. mps._queue.mpsloaded.push(function(){ Form 4 filed by Karuna Therapeutics, Inc. with the security and exchange commission. var mpscall = { Find out the direct holders, institutional holders and mutual fund holders for Karuna Therapeutics, Inc. (KRTX). Find the latest Karuna Therapeutics, Inc. (KRTX) stock discussions in Yahoo Finance's forum. 'cag[device]' : 'web' , Following the completion of the sale, the chief operating officer now owns 45,500 shares in the [â¦] In comparing Karuna Therapeutics, Inc. (KRTX)’s stock with other industry players reveals that stock’s current price change of +0.37% and that of +40.68% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price raised by 0.93% in the last trading and went through an increase of 0.43% in past 12-month trading. mpsload.id = "mps-load"; CNBC_Comscore = 'quotes'; 'content_id' : '101' , Karuna Therapeutics (NASDAQ:KRTX) Stock Price Up 10.7% Posted by Michael Walen on Nov 5th, 2020 // Comments off Shares of Karuna Therapeutics (NASDAQ:KRTX) shot up 10.7% during trading on Tuesday . Historical and current end-of-day data provided by FACTSET. (r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=r.apply(this,arguments);return o.emit(n+"start",arguments,t),t.then(function(e){return o.emit(n+"end",[null,e],t),e},function(e){throw o.emit(n+"end",[e],t),e})})}var o=t("ee").get("fetch"),i=t(21);e.exports=o;var a=window,s="fetch-",c=s+"body-",f=["arrayBuffer","blob","json","text","formData"],u=a.Request,d=a.Response,p=a.fetch,l="prototype";u&&d&&p&&(i(f,function(t,e){r(u[l],e,c),r(d[l],e,c)}),r(a,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t(24)(r);e.exports=r,o.inPlace(window.history,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){c.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){c.emit("jsonp-error",[],p),c.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=s(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),c.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(d);return e&&e.length>=3? mps._queue.adload = mps._queue.adload || []; } A Division of NBCUniversal. Karuna Therapeutics's P/E ratio. Something went wrong while loading Watchlist. }); Find real-time KRTX - Karuna Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Karuna Therapeutics (NASDAQ: KRTX) - P/E: 0.16Ocugen has reported Q2 earnings per share at -0.19, which has decreased by 171.43% compared to Q1, which was -0.07. 'cag[symbol]' : 'KRTX' , Buy Karuna Therapeutics, Inc. stock (KRTX). View the latest KRTX stock quote and chart on MSN Money. Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of Denice Torres, J.D., to its Board of Directors effective December 22, 2020. }); !e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),f.on("addEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-added",[t[1],t[2]],e)}),f.on("removeEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-removed",[t[1],t[2]],e)}),f.on("fn-start",function(t,e,n){e instanceof m&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),f.on("fn-end",function(t,e){this.xhrCbStart&&f.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)})}},{}],16:[function(t,e,n){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]? Karuna Therapeutics Shares March Higher, Can It Continue. script.setAttribute("onerror", "setAdblockerCookie(true);"); Log in to see them here or sign up to get started. BlackRock Inc. owned 4.84% of Karuna […] "host" : 'mps.cnbc.com', Form 4 filed by Karuna Therapeutics, Inc. with the security and exchange commission. s.src = "https://fm.cnbc.com/applications/cnbc.com/resources/files/2020/03/28/VisitorAPI.js"; A high-level overview of Karuna Therapeutics, Inc. (KRTX) stock. } Karuna Therapeutics, Inc. (KRTX) Shares March Higher, Can It Continue? Stock analysis for Karuna Therapeutics Inc (KRTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Visit a quote page and your recently viewed tickers will be displayed here. The stock has moved higher by 14.5% in the ⦠mps._queue.mpsloaded = mps._queue.mpsloaded || []; The Karuna Therapeutics stock forecast is 381.423501 USD for 2021 December 24, ⦠mps.scodePath="//fm.cnbc.com/applications/cnbc.com/staticcontent/scripts/omniture/s_code.js?v=1.6.4.1"; return false; } mps.cloneAd = function() { return false; } Find the latest Karuna Therapeutics, Inc. (KRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. )+[a-zA-Z]{2,}))/; return _regex.test(_qs); "":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],18:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(! Top Insider Buys Highlight for the Week of Jan. 10, The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK. View the latest Karuna Therapeutics Inc. (KRTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. "),a=0;a3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){g.push(t),h&&(x?x.then(a):v?v(a):(E=-E,O.data=E))}function a(){for(var t=0;t34||l<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),f.on("open-xhr-start",function(t){this.params={method:t[0]},i(this,t[1]),this.metrics={}}),f.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),f.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=h(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"===t.type&&(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{f.emit("internal-error",[n])}catch(r){}}};for(var s=0;s
How To Return Tv Ears,
Fuego Hours College Station,
Imran Khan Singer Car Collection,
Websites Where Men Give You Money,
Small World Broken Token,
Meadowlark Botanical Gardens Admission Fee,
Culottes Meaning In Chinese,